Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

seekingalpha.com - Bret Jensen - Ascendis Pharma Stock: Behind The Stock Surge (NASDAQ:ASND)
Ascendis Pharma Stock: Behind The Stock Surge (NASDAQ:ASND)
Seeking Alpha

Ascendis Pharma has more than tripled over the past two and a half years, driven by Yorvipath's blockbuster launch and Yuviwel's FDA approval. Yorvipath's rapid adoption and ongoing label expansion underpin robust revenue growth. Yuviwel-Skytrofa…

digiday.com - Ronan Shields - The rise of pharma ad tech
The rise of pharma ad tech
Digiday - The home of modern media and marketing

Given the risks to patient safety, subsequent litigation risk, government oversight or overall reputational risk, the risk-averse orthodoxy among marketing practitioners in the sector is well understood. However, with the shifting sands at the Food…

forbes.com - Bruce Japsen - Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows
Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows
Forbes

The private equity firm Peak Rock Capital is buying Asembia, a fast-growing provider of services surrounding specialty pharmacy including distribution, group purchasing and technology connecting pharmacies, drug makers, patients and other…

theguardian.com - Andrew Gregory - US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
The Guardian

The NHS will have to divert £45bn from essential services to pay for new medicines under the terms of the UK-US trade deal agreed last December, leading to more than 200,000 avoidable deaths of patients, analysis has found. Ministers have…

mirror.co.uk - Martin Bagot - NHS drug pricing deal with Donald Trump will 'cause more deaths than Covid'
NHS drug pricing deal with Donald Trump will 'cause more deaths than Covid'
Daily Mirror

Britain's drug pricing deal with Donald Trump will cause more deaths than the Covid-19 pandemic if NHS funds are diverted to pay for it, a new study predicted. A health assessment of the US trade deal showed it could lead to 229,000 deaths by 2036…

globenewswire.com - GENFIT S.A. - GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GENFIT Announces U.S. Medicare Coverage and Future Reimbursement for NASHnext, a Non-Invasive Diagnostic Technology to Identify Patients with At-Risk MASH
GlobeNewswire

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext, Labcorp's non-invasive blood-based diagnostic test powered by GENFIT's proprietary NIS4 technology Focuses on patients at highest risk, including those with…

indianexpress.com - Nitendra Pal Singh - UPSC Essentials | Daily subject-wise quiz : Economy MCQs on wage rates for unskilled manual workers under VB-G RAM G, Financial Stability Report and more (Week 169)
UPSC Essentials | Daily subject-wise quiz : Economy MCQs on wage rates for unskilled manual workers under VB-G RAM G, Financial Stability Report and more (Week 169)
The Indian Express

2. The state government can fix their wage rate for different parts of the state. 3. The wage rate notified under the VB G RAM G Act can be lower than the prevailing wage rate notified under Section 6 of the MGNREGA, 2005. How many of the…

seekingalpha.com - Albert Anthony - Rayonier: After Recent Merger, The Bet Is On Synergies And Land Value Appreciation (RYN)
Rayonier: After Recent Merger, The Bet Is On Synergies And Land Value Appreciation (RYN)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

prnewswire.com - Covenant Venture Capital - Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Cision PR Newswire

Hill Research increased revenue approximately fourfold from 2024 to 2025. Over the same period, the company's enterprise value doubled. Heading into 2026, Hill Research is positioned to grow an additional 5 to 8 times, supported by accelerating…

thehindubusinessline.com - BatX Energies raises ₹105 cr in funding round led by IvyCap Ventures
BatX Energies raises ₹105 cr in funding round led by IvyCap Ventures
BusinessLine

Battery recycling and critical minerals recovery firm BatX Energies on Thursday said it has raised ₹105 crore in a funding round led by IvyCap Ventures. The Series A funding round also saw the participation of existing investors Zephyr…

thenational.scot - Alasdair Ferguson - UK-US drug deal could result in 220,000 avoidable deaths in England, analysis finds
UK-US drug deal could result in 220,000 avoidable deaths in England, analysis finds
The National

The NHS in England will have to divert £45 billion from essential services to help pay for new medicines under the terms of the deal agreed between the UK Government and Donald Trump 's US administration last December. Ministers have been…

washingtonmonthly.com - Bill Scher - The Fight in the Democratic Party Is Not Left vs. Center, But Left vs. Left
The Fight in the Democratic Party Is Not Left vs. Center, But Left vs. Left
Washington Monthly

After 15-term Denver-area U.S. Representative Diana DeGette lost her Democratic primary to the 29-year-old Democratic Socialists of America member Melat Kiros, the socialist streamer Hasan Piker, drink in hand, crowed, “Thank you for not…

thehindubusinessline.com - BatX Energies bags ₹105 cr Series A for Battery Recycling
BatX Energies bags ₹105 cr Series A for Battery Recycling
BusinessLine

BatX Energies has secured ₹105 crore in a fresh capital injection. This Series A funding round was led by IvyCap Ventures, with participation from existing investors Zephyr Peacock, the Mankind Pharma Family Office, the Excel Industries…

fool.com - James Halley - Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.
Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.
The Motley Fool

Shares of Alnylam Pharmaceuticals (ALNY +0.44%) have dropped 24% so far this year (through June 30). The biotech company is still a darling of Wall Street analysts, with 14 of 29 analysts following it listing the stock as a buy and seven listing it…

newswire.ca - Michael Goettler Resigns from Bausch Health's Board of Directors
Michael Goettler Resigns from Bausch Health's Board of Directors
CNW

LAVAL, QC, July 1, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief…

Receive a Daily briefing on Pharma Industry News

Get Started